Skip to main content
. Author manuscript; available in PMC: 2023 Nov 16.
Published in final edited form as: Adv Healthc Mater. 2023 Jun 30;12(27):e2301033. doi: 10.1002/adhm.202301033

Figure 6.

Figure 6.

Drug delivery pharmacokinetic evaluation in vivo. A) The serum concentration-time curve of amoxicillin when administered as control pills and ALG-DA pills in pigs. Data is represented as mean ± S.D., n = 3. B) The pharmacokinetic parameters of amoxicillin when administered as control pills and ALG-DA pills in pigs. Data is represented as mean ± S.D., n = 3. C) The serum concentration-time curve of levodopa when administered as control pills and ALG-DA pills in pigs. Data is represented as mean ± S.D., n = 3. D) The pharmacokinetic parameters of levodopa when administered as control pills and ALG-DA pills in pigs. Data is represented as mean ± S.D., n = 3. *indicates p < 0.05, which demonstrates that differences are statistically significant. N.S. indicates that differences are not statistically significant, independent sample T-test.